New Study Shows Legalizing Medical Marijuana May Reduce Crime

Medbox commends data-driven analysis

Mar 31, 2014, 09:00 ET from Medbox, Inc.

LOS ANGELES, March 31, 2014 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (, a leader in providing consulting services and patented medicine storage and dispensing systems to the medical and retail industries, commented today on the recently released study that suggests that legalizing medical marijuana may actually reduce crime.

Researchers at the University of Texas at Dallas looked at the FBI's Uniform Crime Report data across the country, with special interest in the states that have legalized medical marijuana. As reported by the Huffington Post, the study counters concerns that legalization would lead to more crime. These unfounded concerns have been simmering since the first states approved medical marijuana nearly two decades ago, but this study provides data to show that crime rates, particularly certain violent crimes, actually decrease in areas with legal medical marijuana.

"We believe that medical marijuana legalization poses no threat of increased violent crime," Robert Morris, the study's lead author, told The Huffington Post.

Morris, associate professor of criminology, explained, "After controlling for a host of known factors related to changes in crime rates - we accounted for factors such as poverty, employment, education, even per capita beer sales, among other things - we found no evidence of increases in any of these crimes for states after legalizing marijuana for medical use. In fact, for some forms of violence - homicide and assault - we found partial support for declines after the passing of this legislation."

Despite this evidence, many dispensary owners are concerned about crime – an anxiety brought about by the fact that these businesses mostly rely on cash payments, as most banks will not honor credit card transactions used to purchase medical or adult-use marijuana.

Brian Stowe, one of the first licensees in the State of Washington's newly legalized marijuana program, said he is worried about crime. "It's straight up dangerous," Stroh told the Oregonian News. "Anytime there is a known cash business, it puts everyone at risk."

Medbox Vice-President, Matt Feinstein, stated that city/state officials have asked Medbox how to implement crime-reducing monitoring programs. In response Medbox has now begun marketing state-of-the-art monitoring programs to city and state governments.

"We have been approached by city governments to develop city-wide software and hardware platforms to limit abuse and strengthen oversight," he said. "One of the projects we are actively developing is real-time systems for governments with zero upfront fees for implementation to the cash-strapped cities and states."

Management further commented that the systems would involve a real-time biometric chain of custody and tracking solution from the cultivation facility all the way to the point of dispensing. While the exact specifics are being saved for a formal announcement later this year, the system ensures that:

  • physician authorizations are valid,
  • dispensing limits are never exceeded,
  • the correct patient is getting the medicine, and
  • an unalterable transaction record is created so that taxation can be tracked more efficiently.

Medbox has a patent pending on this complete system and a patent issued on one of the key components as well.

"As a leader of this new industry, we have a responsibility to offer solutions to cities and states so they can better serve their citizens in a safe and risk-averse environment," stated Dr. Bruce Bedrick, CEO at Medbox.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, medical dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (, the company offers an industry award winning medical vaporizer product.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact (800) 762-1452 or go online to:


Investor Relations:
Stephen Hart 
Hayden IR 
+1- 917-658-7878 

SOURCE Medbox, Inc.